News

imiquimod

Key words:

Products News

How to choose a suitable for you?

Let us assist you!

Our experts will contact you as soon as possible to meet your needs.

New Products

Trans-4-(trifluoromethyl)cyclohexanecarboxylic acid

(S)-(+)-1-Cyclohexylethylamine

(R)-(-)-1-Cyclohexylethylamine

(R)-(+)-1-Boc-3-Aminopyrrolidine

(R)-(+)-1-Boc-3-Aminopiperidine

Dhakatavir dihydrochloride

Moxifloxacin hydrochloride

New News

The signing and unveiling ceremony of the graduate practice base of Jiangsu University was held in Jiangsu Yongda Pharmaceutical Co., Ltd.

Guanfu Throw 1.8 billion Enters Pharmaceutical Intermediates Target Funds Hungry for IPO

Treatment Technology of Pharmaceutical Intermediates Production Wastewater

The 73rd China International Pharmaceutical API/Intermediate/Packaging/Equipment Fair "Pharmaceutical Environmental Protection Exhibition Group" is in hot recruitment.

Huali has developed a number of steroid pharmaceutical intermediates

Jincheng Pharmaceutical: Actively seek the transformation of the characteristics of intermediate enterprises.

Jiangsu Yongda Pharmaceutical Co., Ltd

Hotline: +86 510-8605 8616

Contact Information

Address: Room 111 and 113, Building 11, No. 600 Tongjiang Middle Road, Xinbei District, Changzhou City

E-mail: huang_meimei@yongdachina.com

peng_ying@yongdachina.com